baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Santhera Pharmaceuticals Holding .../ CH1276028821 /

23/05/2024 13:55:15	Chg. -	Volume	Bid06:00:04	Ask06:00:04	Market Capitalization	Dividend Y.	P/E Ratio
9.440CHF	-	1 Turnover: 9.440	-Bid Size: -	-Ask Size: -	122.42 mill.CHF	-	2.24

GlobeNewswire 18:30 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BATL, DRQ, RPHM, PRFT on Behalf of Sharehol...

GlobeNewswire 18:12 DEADLINE ALERT for MRNS and GRTS: The Law Offices of Frank R. Cruz Reminds Investors of Class Action...

GlobeNewswire 18:06 Kuehn Law Encourages BATL, DRQ, PRFT, and RPHM Investors to Contact Law Firm

GlobeNewswire 14:00 Mineralys Therapeutics Appoints Biopharmaceutical Executive Alexander M. Gold, M.D. to its Board of ...

GlobeNewswire 14:00 Findings on the Burdens of Diabetic Peripheral Neuropathic Pain (DPNP) Among Three Lexicon-Sponsored...

GlobeNewswire 13:30 Intellia Therapeutics Names Brian Goff to its Board of Directors

GlobeNewswire 13:00 TScan Therapeutics Announces Updates to its Board of Directors

GlobeNewswire 09:00 Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimila...

GlobeNewswire 03:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bio...

GlobeNewswire 13/06 Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering

GlobeNewswire 13/06 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron Pharma...

GlobeNewswire 13/06 Nkarta Adds Experienced Leader in Autoimmune R&D, George Vratsanos, M.D., FACR, to Board of Director...

GlobeNewswire 13/06 SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Marinus Pharmac...

GlobeNewswire 13/06 American Kidney Fund Convenes Rare Kidney Disease Action Network to Advocate for Policies and Regula...

GlobeNewswire 13/06 Novartis' Fabhalta Shows Promise in Addressing Critical Gaps in C3 Glomerulopathy Treatment

GlobeNewswire 12/06 Investment Opportunity: PlantForm Corporation Seeks $25M to Accelerate Plant-Based Medical Breakthro...

GlobeNewswire 11/06 SIPP Industries Announces Strategic R&D Agreement with Calypso Pharmaceuticals to Develop Nano-Emuls...

GlobeNewswire 11/06 Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b...

GlobeNewswire 11/06 60 Degrees Pharmaceuticals Receives FDA Orphan Drug Designation for Tafenoquine for Treatment of Pat...

GlobeNewswire 11/06 NMD Pharma Initiates Phase 2b Trial of NMD670 in Generalized Myasthenia Gravis Patients

GlobeNewswire 11/06 Alvotech and STADA add to strategic alliance through denosumab partnership

GlobeNewswire 11/06 NMD Pharma Initiates Phase 2b Trial of NMD670 in Generalized Myasthenia Gravis Patients

GlobeNewswire 11/06 ROSEN, A LONGSTANDING LAW FIRM, Encourages Marinus Pharmaceuticals, Inc. Investors to Secure Counsel...

GlobeNewswire 10/06 Sermonix Pharmaceuticals Announces Breast Cancer Research Publication of Paper Examining Lasofoxifen...

GlobeNewswire 10/06 Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus He...

Santhera Pharmaceuticals Holding .../ CH1276028821 /

If you wish to receive reply to your feedback, please provide your email address.